Claros Diagnostics Lands $4,000,000 Series B Financing Round

  • Feed Type
  • Date
  • Company Name
    Claros Diagnostics
  • Mailing Address
    4 Constitution Way Woburn, MA 01801
  • Company Description
    Claros has developed a novel handheld immunoassay system incorporating a lab-on-a-chip configuration which produces high performance quantitative laboratory blood test results with the ease-of-use of rapid qualitative diagnostic test strips. The Claros device will enable the physician to quantitatively analyze a blood sample in the office, allowing completion of the examination within the timeframe of the visit. The Company will initially focus on developing its diagnostic system for urological cancer, incorporating an established panel of biomarkers, anchored by PSA (prostate-specific antigen).
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Oxford Bioscience Partners
  • Venture Investor
    Bioventures Investors
  • Venture Investor
    Commons Capital
  • Venture Investor

Trending on Xconomy